Xconomy’s Digital Events →
Brad Vale is the head of Johnson & Johnson Development Corp., the company’s venture capital group.
Sponsored · Webinar
Provide an in vitro drug-induced proarrhythmia assessment & strengthen pharmacological safety profiles of drug candidates
Sponsored · Video
A Fireside Chat with Medpace's Regulatory Affairs Director David Horton
Xconomy Insight · Special Report
Insights, wisdom, and inspiration on what it takes
© 2007-2021, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.